Jubilant Pharmova530019New rating assigned
ICRA assigns [ICRA]AA+ (Stable) to Jubilant Pharmova's proposed Rs. 1,400.00 crore non-convertible debentures
By ScoutQuest · · 1 min read
[ICRA]AA+Assigned · ICRA Limited
- Rating Assigned
- [ICRA]AA+ (Stable)
- Rated Amount
- Rs. 1,400.00 crore
- Instrument Rated
- proposed non-convertible debenture programme
- Agency
- ICRA Limited
- Action
- Assigned
ICRA assigns [ICRA]AA+ (Stable) to Jubilant Pharmova's proposed Rs. 1,400.00 crore non-convertible debentures.
ICRA rating letter date
Rating communication received at 5:09 p.m. (IST)
Company disclosure letter date
Also from Jubilant Pharmova
India Ratings assigns IND AA+/Stable to Jubilant Pharmova's proposed NCDs of Rs. 1,400.00 crore
21 Oct 2026
Board approves up to 80,000 NCDs of ₹1,00,000 each, aggregating up to ₹800 crore, on private placement basis
12 Oct 2026
Board approves NCD issue of up to ₹800 crore, seeks members' nod for ₹2,500 crore debt securities
12 Oct 2026
More numbers
- Proposed non-convertible debentures rated amount1,400.00 (₹ crore)
- Total rated amount1,400.00 (Rs. crore)
Source: BSE · 14 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.